Julie Lorent

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

Maria De Santis, Joaquim Bellmunt, Graham M. Mead et al. · Journal of Clinical Oncology · 2011 · 773 citations · Full text

Medicine, Oncology, Pharmacology +13

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells

Yumeng Mao, Vincent van Hoef, Xiaonan Zhang et al. · Blood · 2016 · 169 citations · Full text

Life Sciences, Immunology, Oncology +15

Generally applicable transcriptome-wide analysis of translation using anota2seq

Christian Oertlin, Julie Lorent, Carl Murie et al. · Nucleic Acids Research · 2019 · 107 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

Polysome-profiling in small tissue samples

Shuo Liang, Hermano Martins Bellato, Julie Lorent et al. · Nucleic Acids Research · 2017 · 78 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Immune gene expression and response to chemotherapy in advanced breast cancer

Theodoros Foukakis, John Lövrot, Alexios Matikas et al. · British Journal of Cancer · 2018 · 52 citations · Full text

Medicine, Immunology, Oncology +15